MAPK3 and graft versus host disease: In support of the concept that RAS/ERK signaling plays a role in inflammation, recent studies had shown that ERK1/2 phosphorylation is critical for allogeneic immune activation during graft-versus-host disease (GVHD)16 and MEK inhibition blocked these pro-inflammatory events17.